Champions Oncology, Inc. CSBR
4.90
(0.05)
(1.01%)
as of 25 Sep
- Market cap
- $68.9M
- P/E
- 0.0×
Follow CSBR
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
100.24% | (46.96%) | (29.97%) | (28.38%) | |
| 8.89% | (7.83%) | (3.96%) | (3.56%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (626.23%) | |
Return on Tangible Assets |
78.36% | (71.96%) | (41.62%) | (26.09%) | |
Average Days of Receivables |
72.09 | 76.01 | 80.94 | 81.84 | |
Free Cash Flow per Share |
0.41 | 0.28 | (0.36) | (0.44) | |
Free Cash Flow |
5.64 | 3.84 | (5.01) | (6.11) | |
Capital Expenditures |
(0.58) | (0.55) | (0.54) | (0.55) | |
Piotroski F-Score |
7.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
48.82% | 38.19% | (50.02%) | (63.10%) | |
Accounts Receivable Turnover |
5.31 | 4.16 | 4.87 | 5.26 | |
Accounts Payable Turnover |
5.37 | 5.80 | 5.54 | 5.81 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
75.05 | 66.64 | 81.54 | 67.53 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.03 | (0.02) | 0.26 | 0.27 | |
Research and Development Expense of Revenue |
14.34% | 15.41% | 15.29% | 15.41% | |
Selling, General and Administrative Expense of Revenue |
31.55% | 34.30% | 34.45% | 35.95% | |
Share Based Compensation of Revenue |
1.44% | 1.74% | 2.08% | 2.96% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.53 | (1.90) | 3.81 | 4.90 | |
Depreciation/Fixed assets |
0.38 | 0.39 | 0.39 | 0.35 | |
Capex/Depreciation |
(0.39) | (0.38) | (0.39) | (0.41) | |
Revenue per Share |
4.24 | 4.17 | 4.30 | 4.36 | |
Operating CF per Share |
0.45 | 0.32 | (0.32) | (0.40) | |
Capex per Share |
(0.04) | (0.04) | (0.04) | (0.04) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
4.21% | (3.99%) | (1.98%) | (1.87%) |
Columns are period end dates